相似文献
1
An Approach to Pediatric or Mentally Deficient Donors from a Bioethical Perspective: Considerations and Recommendations on Behalf of the Donor Research Team of the Turkish Society of Hematology (DART).
Turk J Haematol. 2022 Aug 25;39(3):220-221. doi: 10.4274/tjh.galenos.2022.2022.0172. Epub 2022 Jun 14.
2
Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
Biol Blood Marrow Transplant. 2016 Jan;22(1):96-103. doi: 10.1016/j.bbmt.2015.08.017. Epub 2015 Aug 22.
3
Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology.
Transfus Apher Sci. 2018 Jun;57(3):316-322. doi: 10.1016/j.transci.2018.05.012. Epub 2018 May 16.
4
Comparable Outcome with a Faster Engraftment of Optimized Haploidentical Hematopoietic Stem Cell Transplantation Compared with Transplantations from Other Donor Types in Pediatric Acquired Aplastic Anemia.
Biol Blood Marrow Transplant. 2019 May;25(5):965-974. doi: 10.1016/j.bbmt.2019.01.010. Epub 2019 Jan 11.
5
[Information and consent forms for hematopoietic stem cell transplantation donors and recipients: Guidelines from the Franchophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Bull Cancer. 2016 Nov;103(11S):S198-S200. doi: 10.1016/j.bulcan.2016.09.022. Epub 2016 Nov 11.
6
Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission.
Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD008818. doi: 10.1002/14651858.CD008818.pub2.
7
[Allogeneic hematopoietic stem cell transplantations].
Transfus Clin Biol. 2011 Apr;18(2):235-45. doi: 10.1016/j.tracli.2011.02.021. Epub 2011 Apr 3.
8
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2017 Apr;23(4):552-561. doi: 10.1016/j.bbmt.2017.01.009. Epub 2017 Jan 5.
9
[A novel quantitative approach to donor chimerism and its clinical effect after allogenic hematopoietic stem cell transplantation].
Zhonghua Er Ke Za Zhi. 2006 Jul;44(7):540-1.
10
Graft manipulation and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation from mismatched unrelated and mismatched/haploidentical related donors in pediatric leukemia patients.
J Pediatr Hematol Oncol. 2010 Apr;32(3):e85-90. doi: 10.1097/MPH.0b013e3181cf813c.
本文引用的文献
1
Moral Distress: Its Manifestations in Healthy Donors during Peripheral Blood Hematopoietic Stem Cell Harvesting.
Transplant Cell Ther. 2021 Oct;27(10):853-858. doi: 10.1016/j.jtct.2021.06.005. Epub 2021 Jun 12.
2
Exploring moral distress in potential sibling stem cell donors.
Nurs Ethics. 2013 Mar;20(2):178-88. doi: 10.1177/0969733012452682. Epub 2012 Nov 2.
3
Family donor care management: principles and recommendations.
Bone Marrow Transplant. 2010 Aug;45(8):1269-73. doi: 10.1038/bmt.2009.354. Epub 2009 Dec 21.
4
To stay or to go, to speak or stay silent, to act or not to act: moral distress as experienced by psychologists.
Ethics Behav. 2005;15(3):197-212. doi: 10.1207/s15327019eb1503_1.
5
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
Pediatr Blood Cancer. 2006 Apr;46(4):422-33. doi: 10.1002/pbc.20708.
6
Designing an ethical policy for bone marrow donation by minors and others lacking capacity.
Camb Q Healthc Ethics. 2004 Spring;13(2):149-55. doi: 10.1017/s0963180104132064.
Zotero 插件